{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:54:32Z","timestamp":1775584472247,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:p>The objective of this study was to investigate the predictors and predictive model construction of the progression of HBV-Pre.Acute-on-chronic liver failure (ACLF), a total of 133 patients with HBV-Pre.ACLF was divided into the progressive group (52 patients) and the recovery group (81 patients) according to whether they progressed to ACLF or not. The clinical parameters N%, L%, PLT, ALT, TBiL, ALB, Cre, Na, NH3, CRP, AFP, prothrombin time (PT), international normalized ratio (INR), FIB, and their rate of change at baseline were analyzed in the 2 groups. The independent risk factors for HBV-Pre.ACLF progression was found by univariate and multivariate analyses, and a predictive model was constructed. The clinical parameters ALB, FIB, Na, combined alprostadil treatment and MELD, and MELD-Na scores at baseline were significantly different between the 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;.05), while ALT, TBiL, Cre, CHE, NH3, N%, L%, PLT, INR, and PT were not significantly different (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt;.05). The change rates of Na, CHE, PT, FIB, CRP, Cre, PLT, and the ratio after to before of N% were significantly different between the 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;.05), while the change rates of ALT, TBIL, NH3, AFP, L%, and the ratio after to before of INR were not significantly different between the 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt;.05). Univariate and multivariate analyses showed that baseline ALB, Na, FIB, combined alprostadil therapy and the rate of change of Na and PLT were protective factors for disease progression, and the rate of change of PT, CRP, and the ratio after to before of N% were independent risk factors for disease progression. The novel model was LogitP\u2005=\u2005\u22126.051\u2005+\u20054.049\u00d7\u0394PT\u2005+\u20050.626\u00d7\u0394CRP\u2005+\u20054.527\u00d7the ratio after to before N% and its area under the curve was 0.944 (95% confidence interval: 0.900<jats:bold>\u2013<\/jats:bold>0.988) predicting progression of HBV-Pre.ACLF, and the best cutoff value was \u22120.22. The patients with a higher logitP score (&gt; \u22120.22) had an increased risk for progression to ACLF (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;.05). The novel model logitP shows good predictive value for the disease progression of HBV-Pre.ACLF.<\/jats:p>","DOI":"10.1097\/md.0000000000040246","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:01:34Z","timestamp":1730214094000},"page":"e40246","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The rate of change in clinical indicators can predict the progression of hepatitis B virus-related acute-on-chronic preliver failure"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6292-2252","authenticated-orcid":false,"given":"Jun","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Intensive Care Unit, Infectious Disease Hospital Affiliated to Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, Infectious Disease Hospital Affiliated to Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, Infectious Disease Hospital Affiliated to Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, Infectious Disease Hospital Affiliated to Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-2436","authenticated-orcid":false,"given":"Daya","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"18","article-title":"Guideline for diagnosis and treatment of liver failure.","volume":"27","year":"2019","journal-title":"Chin J Hepatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL):an update.","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11938-019-00236-3","article-title":"Updates on chronic HBV: current challenges and future goals.","volume":"17","author":"Lee","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","article-title":"HBV\/HIV coinfection: impact on the development and clinical treatment of liver diseases.","volume":"8","author":"Cheng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R5-20250504","first-page":"289","article-title":"Concerns and preventive interventions in the treatment of pre-hepatic failure.","volume":"28","author":"Duan","year":"2020","journal-title":"Chin J Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirthosis.","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"R7-20250504","first-page":"298","article-title":"Advances in early warning and treatment of pre-hepatic failure.","volume":"28","author":"Zhu","year":"2020","journal-title":"Chin J Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/hepr.12567","article-title":"Predictors of progression into acute-on-chronic liver failure from acute deterioration of pre-existing chronic liver disease.","volume":"46","author":"Zhang","year":"2016","journal-title":"Hepatol Res"},{"key":"R9-20250504","first-page":"2434","article-title":"Survival advantage of patients with acute-on-chronic pre-liver failure treated with artificial liver: a multi-center study.","volume":"38","author":"Zhu","year":"2022","journal-title":"J Pract Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001704","article-title":"The MELD score is superior to the maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: a global study.","volume":"117","author":"Morales-Arraez","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.","volume":"67","author":"Wu","year":"2018","journal-title":"Gut"},{"key":"R12-20250504","first-page":"1496","article-title":"Study on the application value of MELD-Na, CLIF-C OFs, COSSH-ACLFs and NLR scoring systems in patients with hepatitis B virus related acute-on-chronic liver failure.","volume":"32","author":"Miao","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure.","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"R14-20250504","first-page":"e13175","article-title":"Hyponatremia and its correlation with hepatic encephalopathy and severity of liver disease.","volume":"13","author":"Younas","year":"2021","journal-title":"Cureus"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hep4.1829","article-title":"Low serum cholinesterase identifies patients with worse outcome and increased mortality after TIPS.","volume":"6","author":"Stockhoff","year":"2022","journal-title":"Hepatol Commun"},{"key":"R16-20250504","first-page":"e16342","article-title":"Thrombocytopenia in chronic liver disease: challenges and treatment strategies.","volume":"13","author":"Desai","year":"2021","journal-title":"Cureus"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/biom11081195","article-title":"C-reactive protein is an independent predictor of 30-day bacterial infection post-liver transplantation.","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"},{"issue":"Suppl 1","key":"R18-20250504","first-page":"170","article-title":"The impact of sterile inflammation in acute liver injury.","volume":"3","author":"Woolbright","year":"2017","journal-title":"J Clin Transl Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","article-title":"The role of monocytes and macrophages in acute and acute-on-chronic liver failure.","volume":"9","author":"Triantafyllou","year":"2018","journal-title":"Front Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0042-1755274","article-title":"Management of acute liver failure: update 2022.","volume":"42","author":"Tujios","year":"2022","journal-title":"Semin Liver Dis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.21873\/invivo.11899","article-title":"Predictive ability of preoperative PT-INR and postoperative MCP1 for post-hepatectomy liver failure.","volume":"34","author":"Arisaka","year":"2020","journal-title":"In Vivo"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","article-title":"Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure.","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/CM9.0000000000000298","article-title":"Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.","volume":"132","author":"Tong","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.32252","article-title":"Letter to the editor: the addition of C-reactive protein and von Willebrand factor to model for end-stage liver disease-sodium.","volume":"75","author":"Luo","year":"2022","journal-title":"Hepatology"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep.31838","article-title":"The addition of C-reactive protein and von Willebrand factor to model for end-stage liver disease-sodium improves prediction of waitlist mortality.","volume":"74","author":"Starlinger","year":"2021","journal-title":"Hepatology"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e004024","DOI":"10.1136\/jitc-2021-004024","article-title":"C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.","volume":"10","author":"Kl\u00fcmper","year":"2022","journal-title":"J Immunother Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:54:25Z","timestamp":1746320065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":26,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040246","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}